ERBB2 and gastric cancer: In contrast, RN87 gastric cancer xenografts that progressed on T-DM1, T-DXd, or both, or progressed on DV (as shown in the model in Fig. 4A), still expressed HER2 strongly (Supplementary Fig. S7A-E).